• University of Miami (UMiami) commences clinical use of CT:VQ™
• UMiami becomes second U.S. academic medical centre to begin clinical use of CT:VQ™
• Arrangement provides three months of introductory pricing prior to full commercial terms

4DMedical Limited (ASX:4DX), a global leader in respiratory imaging technology, today announces that the University of Miami has entered into a commercial arrangement for the clinical use of CT:VQ™. The University of Miami, a leading academic medical centre with a nationally recognised pulmonary medicine program, has commenced clinical use of CT:VQ™ under a structured launch framework. An introductory pricing period will apply for the first three months prior to full commercial terms, supporting early clinical adoption and workflow establishment. 4DMedical is working to build a strong network of leading academic medical centres (AMCs) to drive broad adoption of CT:VQ™ across the U.S. market. UMiami is the second U.S. academic medical center, following Stanford, to adopt CT:VQ™ for clinical use in the past two months, providing strong validation of the Company's commercialisation strategy. The commercial launch at UMiami follows exceptionally strong clinician engagement at RSNA, with leading radiologists from across the United States engaging with 4DMedical to learn more about CT:VQ™ and how it can help both their practices and their patients. 4DMedical has also signed a two-year agreement with Lahey Hospital & Medical Center (Lahey Clinic), a nationally recognised leader in pulmonary medicine and interventional pulmonology. Under the agreement, Lahey will deploy 4DMedical's Lung Density Analysis™ (LDA) and IQ-UIP™ software on an annual subscription model with capacity for up to 24,000 scans per annum.

4DMedical is moving with incredible speed and the Company is excited by the momentum. The Company looks forward to keeping the market updated as it advances its strategy of winning key U.S. academic medical centres as reference sites for CT:VQ™.